Frank-D. Goebel

485 total citations
7 papers, 348 citations indexed

About

Frank-D. Goebel is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Frank-D. Goebel has authored 7 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Frank-D. Goebel's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (2 papers). Frank-D. Goebel is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (2 papers). Frank-D. Goebel collaborates with scholars based in Germany, Belgium and Australia. Frank-D. Goebel's co-authors include Johannes R. Bogner, Volker Vielhauer, Gerlinde M. Michl, L. Wille, R Beckmann, Bernd Salzberger, A. P. Fiddian, Georg Stingl, David A. Cooper and Juan González‐Lahoz and has published in prestigious journals such as New England Journal of Medicine, AIDS and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Frank-D. Goebel

7 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank-D. Goebel Germany	5	260	230	114	74	26	7	348
Fabienne Caby France	9	232 0.9×	231 1.0×	123 1.1×	92 1.2×	24 0.9×	26	365
Eugénio Teófilo Portugal	9	254 1.0×	178 0.8×	63 0.6×	74 1.0×	13 0.5×	22	319
J Lange Netherlands	9	193 0.7×	147 0.6×	56 0.5×	55 0.7×	15 0.6×	17	248
Antonio Antela Spain	8	300 1.2×	214 0.9×	98 0.9×	57 0.8×	25 1.0×	22	353
Bruce Rashbaum United States	6	340 1.3×	235 1.0×	137 1.2×	68 0.9×	19 0.7×	9	384
Irina Magdalena Dumitru Romania	7	367 1.4×	272 1.2×	85 0.7×	88 1.2×	45 1.7×	26	451
Alberto Arranz Spain	10	473 1.8×	334 1.5×	146 1.3×	47 0.6×	17 0.7×	16	504
Peter Cardiello Thailand	11	374 1.4×	279 1.2×	70 0.6×	82 1.1×	11 0.4×	13	423
Melchor Riera Spain	12	226 0.9×	136 0.6×	86 0.8×	131 1.8×	15 0.6×	35	356
Naomi Givens United Kingdom	9	566 2.2×	399 1.7×	200 1.8×	107 1.4×	35 1.3×	17	609

Countries citing papers authored by Frank-D. Goebel

Since Specialization

Citations

This map shows the geographic impact of Frank-D. Goebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank-D. Goebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank-D. Goebel more than expected).

Fields of papers citing papers by Frank-D. Goebel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank-D. Goebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank-D. Goebel. The network helps show where Frank-D. Goebel may publish in the future.

Co-authorship network of co-authors of Frank-D. Goebel

This figure shows the co-authorship network connecting the top 25 collaborators of Frank-D. Goebel. A scholar is included among the top collaborators of Frank-D. Goebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank-D. Goebel. Frank-D. Goebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Goebel, Frank-D., R Hemmer, Jean-Claude Schmit, et al.. (2001). Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy. AIDS. 15(1). 33–45. 34 indexed citations

2.

Bogner, Johannes R., Volker Vielhauer, R Beckmann, et al.. (2001). Stavudine Versus Zidovudine and the Development of Lipodystrophy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(3). 237–244. 87 indexed citations

3.

Bogner, Johannes R., Volker Vielhauer, R Beckmann, et al.. (2001). Stavudine Versus Zidovudine and the Development of Lipodystrophy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(3). 237–244. 37 indexed citations

4.

Schaller, U., Gerlinde M. Michl, Frank-D. Goebel, & Volker Klauß. (1999). Acute hypopyon uveitis in a patient with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex (MAC) infection with rifabutin. Der Ophthalmologe. 96(4). 267–269. 3 indexed citations

5.

Goebel, Frank-D., Josef W. Mannhalter, Robert B. Belshe, et al.. (1999). Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. AIDS. 13(12). 1461–1468. 24 indexed citations

6.

Cooper, David A., José M. Gatell, Susanne Kroon, et al.. (1993). Zidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter. New England Journal of Medicine. 329(5). 297–303. 161 indexed citations

7.

Willer, Andreas, U. Heinzmann, W. Mellert, et al.. (1993). Reduction of HIV-1 antigen production by phosphatidylcholine containing formulations via growth inhibition of HIV-1-infected cells. Research in Experimental Medicine. 193(1). 123–135. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact